NDC 64406-020

Vumerity

Diroximel Fumarate

Vumerity is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Biogen Inc.. The primary component is Diroximel Fumarate.

Product ID64406-020_0e2eed60-ee1e-4178-b1d9-99d2df967986
NDC64406-020
Product TypeHuman Prescription Drug
Proprietary NameVumerity
Generic NameDiroximel Fumarate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2019-10-29
Marketing CategoryNDA / NDA
Application NumberNDA211855
Labeler NameBiogen Inc.
Substance NameDIROXIMEL FUMARATE
Active Ingredient Strength231 mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 64406-020-01

1 BOTTLE, PLASTIC in 1 CARTON (64406-020-01) > 106 CAPSULE in 1 BOTTLE, PLASTIC
Marketing Start Date2019-10-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64406-020-01 [64406002001]

Vumerity CAPSULE
Marketing CategoryNDA
Application NumberNDA211855
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-10-29

NDC 64406-020-03 [64406002003]

Vumerity CAPSULE
Marketing CategoryNDA
Application NumberNDA211855
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-10-29

NDC 64406-020-05 [64406002005]

Vumerity CAPSULE
Marketing CategoryNDA
Application NumberNDA211855
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-29

Drug Details

Active Ingredients

IngredientStrength
DIROXIMEL FUMARATE231 mg/1

Trademark Results [Vumerity]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VUMERITY
VUMERITY
90777844 not registered Live/Pending
Biogen MA Inc.
2021-06-16
VUMERITY
VUMERITY
87476946 5908620 Live/Registered
Alkermes Pharma Ireland Limited
2017-06-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.